Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660 View more
Data Presented at ISET Shows Impressive Revascularization in Chronic Total Occlusions with FLEX Vessel Prep System View more
